Building "Bridges" Across the Bayou City!
Securities trading for two Houston-based biotechnology firms have resumed after regulators questioned recent claims regarding potential Covid-19 treatments.
Both Moleculin Biotech Inc. (Nasdaq: MBRX) and CNS Pharmaceuticals Inc. (Nasdaq: CNSP) resume…
Read MoreThe Nasdaq stock exchange halted trading for two Houston-based biotech companies as regulators question their recent claims regarding Covid-19 treatments.
Moleculin Biotech Inc. (Nasdaq: MBRX) and CNS Pharmaceuticals Inc. (Nasdaq: CNSP), both headqua…
Read MoreSecurities trading for two Houston-based biotechnology firms is temporarily halted as the U.S. Securities and Exchange Commission questions recent claims made by the companies regarding Covid-19 treatments.
Moleculin Biotech Inc. (Nasdaq: MBRX) and C…
Read MoreTwo publicly traded, clinical-stage pharmaceutical companies in Houston worked to better their financial runways Feb. 6 āĀ one through a share purchase agreement, the other through a reverse stock split.
Houston-based Moleculin Biotech Inc. (Nasdaq…
Read More